Methods for treating Pompe disease

Details for Australian Patent Application No. 2007322123 (hide)

Owner Zystor Therapeutics, Inc.

Inventors Maga, John; Lebowitz, Jonathan

Agent Pizzeys

Pub. Number AU-A-2007322123

PCT Pub. Number WO2008/063511

Priority 60/879,255 05.01.07 US; 60/858,514 13.11.06 US; 60/900,187 07.02.07 US

Filing date 13 November 2007

Wipo publication date 29 May 2008

International Classifications

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/063511 Priority application(s): WO2008/063511

24 March 2011 Assignment before Grant

  Zystor Therapeutics, Inc. The application has been assigned to BioMarin Pharmaceutical Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007322130-System for the treatment of heart tissue

2007322116-Cyclohexenyl-aryl compounds for inflammation and immune-related uses